We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.68%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$604M
AUM Growth
-$213M
(-26%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-30.79%
Top 10 Holdings %
Top 10 Hldgs %
13.62%
Holding
1,036
New
389
Increased
70
Reduced
105
Closed
470
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$12.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$10.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.35M |
| 4 |
Workday
WDAY
|
+$7.63M |
| 5 |
Coca-Cola
KO
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$15.4M |
| 2 |
Amgen
AMGN
|
+$11.2M |
| 3 |
Salesforce
CRM
|
+$9.62M |
| 4 |
Danaher
DHR
|
+$9.18M |
| 5 |
Union Pacific
UNP
|
+$8.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.33% |
| 2 | Consumer Discretionary | 16.35% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Pagaya Technologies
PGY
$1.35B
| $134K | 0.02% |
+12,810
| New | +$142K |
|
527
Petco
WOOF
$797M
| $133K | 0.02% |
43,700
+18,500
| +73% | +$57.9K |
|
|
BBBY
528
Bed Bath & Beyond
BBBY
$479M
| $127K | 0.02% |
+24,125
| New | +$146K |
|
529
Ocular Therapeutix
OCUL
$1.83B
| $125K | 0.02% |
+17,000
| New | +$131K |
|
530
Adecoagro
AGRO
$1.4B
| $124K | 0.02% |
+11,100
| New | +$114K |
|
531
New Fortress Energy
NFE
$92.9M
| $124K | 0.02% |
+14,900
| New | +$184K |
|
532
NeoGenomics
NEO
$1.99B
| $123K | 0.02% |
+13,000
| New | +$162K |
|
533
Latham Group
SWIM
$660M
| $123K | 0.02% |
+19,142
| New | +$129K |
|
534
WisdomTree
WT
$2.79B
| $120K | 0.02% |
13,500
-2,779
| -17% | -$25.9K |
|
|
AGNT
535
AGNT Inc
AGNT
$629M
| $120K | 0.02% |
+12,262
| New | +$130K |
|
536
Immersion
IMMR
$243M
| $112K | 0.02% |
14,813
| – | – |
|
537
Arcus Biosciences
RCUS
$3.33B
| $111K | 0.02% |
+14,200
| New | +$165K |
|
538
Bit Digital
BTBT
$428M
| $108K | 0.02% |
+53,500
| New | +$154K |
|
539
Arcos Dorados Holdings
ARCO
$1.74B
| $103K | 0.02% |
+12,800
| New | +$101K |
|
540
Helix Energy Solutions
HLX
$1.34B
| $102K | 0.02% |
+12,300
| New | +$104K |
|
541
Inogen
INGN
$174M
| $101K | 0.02% |
+14,099
| New | +$133K |
|
542
Organogenesis Holdings
ORGO
$324M
| $98.9K | 0.02% |
+22,900
| New | +$92.5K |
|
543
Vir Biotechnology
VIR
$1.46B
| $98.7K | 0.02% |
+15,226
| New | +$135K |
|
544
Target Hospitality
TH
$1.43B
| $95.1K | 0.02% |
+14,456
| New | +$116K |
|
545
Sabre
SABR
$716M
| $94.1K | 0.02% |
33,500
-41,882
| -56% | -$148K |
|
|
NAGE
546
Niagen Bioscience
NAGE
$256M
| $93.2K | 0.02% |
+13,500
| New | +$84.8K |
|
547
Bioventus
BVS
$889M
| $92.8K | 0.02% |
+10,146
| New | +$101K |
|
548
Ardelyx
ARDX
$1.24B
| $92.8K | 0.02% |
18,900
-31,500
| -63% | -$169K |
|
549
Lloyds Banking Group
LYG
$85.2B
| $92.4K | 0.02% |
+24,200
| New | +$80K |
|
550
Gaotu Techedu
GOTU
$405M
| $83.9K | 0.01% |
+25,826
| New | +$71.3K |
|
Similar funds
KL
FWS
AGFVA
1C
MP
FLC
APW
QM
Bayesian Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Bayesian Capital Management held 1,036 positions worth $604M, down 26% from $817M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management withdrew a net $186M in Q1 2025, closing 470 positions and reducing 105 holdings. Its most notable exit was Amgen, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Advanced Micro Devices worth $9.96M.
- Bayesian Capital Management's largest Q1 2025 buy was Advanced Micro Devices: 96,900 shares worth $9.96M.
- Bayesian Capital Management added most to Cisco in Q1 2025, an estimated $12.4M increase.
- Bayesian Capital Management's biggest Q1 2025 reduction was Nike, cutting an estimated $15.4M.
- Bayesian Capital Management fully exited Amgen in Q1 2025, selling an estimated $11.2M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $604M portfolio in Q1 2025.
- Bayesian Capital Management opened 389 new positions and closed 470 in Q1 2025.
- Bayesian Capital Management's portfolio value fell 26% quarter-over-quarter to $604M.
Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.